Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
287 studies found for:    Open Studies | "Embolism and Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Embolism and Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Not yet recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
3 Recruiting A Complex Contraception Registry
Conditions: Diabetes;   Cardiovascular Disease;   Epilepsy;   Migraine;   Neurological Disorders;   Cancer;   Bariatric Surgery Candidate;   Organ or Tissue Transplant; Complications;   Lupus Erythematosus, Systemic;   Other Hematologic Conditions;   Other Venous Embolism and Thrombosis
Intervention:
4 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
5 Recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
6 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
7 Recruiting Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
Condition: Sinus Thrombosis, Intracranial
Interventions: Drug: Endovascular thrombolysis;   Drug: Heparin
8 Unknown  Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Conditions: Coronary Artery Disease;   Acute Cerebrovascular Accident;   Intracranial Embolism;   Embolism, Air
Intervention: Device: ROCsafeTM
9 Recruiting Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
Conditions: Extracorporeal Circulation;   Inflammation;   Blood Coagulation;   Intracranial Embolism
Intervention: Device: MECC system with rheoparin coating
10 Recruiting OCT in Retinal Vein Occlusions
Condition: Retinal Vein Occlusions
Intervention:
11 Unknown  Pulmonary Embolism: Multifunctional Assessment of Prognosis
Condition: Pulmonary Embolism
Intervention:
12 Not yet recruiting Use of Gadolinium in CT Pulmonary Angiography
Condition: Pulmonary Embolism
Intervention: Drug: Gadolinium
13 Recruiting Venous Thrombectomy/Thrombolysis Outcome Registry
Conditions: Deep Venous Thrombosis;   Post Thrombotic Syndrome
Intervention:
14 Recruiting Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection
Condition: Deep Venous Thrombosis
Intervention:
15 Recruiting Prophylaxis of Venous Thromboembolism After Bariatric Surgery
Conditions: Morbid Obesity;   Thromboembolism;   Bypass Complications
Intervention: Drug: Nadroparin
16 Unknown  A Pilot Study in Cancer Patients With Central Line Associated Blood Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
Conditions: Neoplasm;   Central Venous Catheter Thrombosis
Intervention: Drug: Rivaroxaban
17 Unknown  Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
Conditions: Retinal Vein Occlusion;   Posterior Vitreous Detachment
Intervention: Drug: Ranibizumab
18 Unknown  Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
Condition: Venous Thrombosis
Intervention: Drug: long-lasting OAT or 12-month OAT
19 Unknown  National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients
Conditions: Neoplasms;   Venous Thromboembolism
Intervention: Procedure: VTE treatment in cancer patient description
20 Recruiting Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Conditions: Macular Edema;   Central Retinal Vein Occlusion
Interventions: Drug: Ozurdex;   Drug: Avastin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years